Hepatotoxicity of alpha-methyldopa in pregnancy

J Clin Pharm Ther. 2010 Jun;35(3):361-3. doi: 10.1111/j.1365-2710.2009.01078.x.

Abstract

Alpha-methyldopa is one of the most widely prescribed antihypertensive agents used during pregnancy. Despite its known potential hepatotoxicity, there have been only a few reports describing hepatotoxicity with the use of this drug during pregnancy. We report here a new case of acute hepatitis in a pregnant woman related to the use of alpha-methyldopa, and briefly review the literature on alpha-methyldopa-induced hepatotoxicity in pregnancy.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Adult
  • Antihypertensive Agents / adverse effects*
  • Antihypertensive Agents / therapeutic use
  • Chemical and Drug Induced Liver Injury / etiology*
  • Female
  • Humans
  • Hypertension, Pregnancy-Induced / drug therapy
  • Methyldopa / adverse effects*
  • Methyldopa / therapeutic use
  • Pregnancy

Substances

  • Antihypertensive Agents
  • Methyldopa